Samson Mataraso

Title: Innovations by Samson Mataraso in Glycemic Dysregulation and Cardiovascular Disease

Introduction

Samson Mataraso is an innovative inventor based in Stanford, CA. He has made significant contributions to the field of medical technology, particularly in the evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease. His work focuses on developing methods that can enhance patient care and treatment outcomes.

Latest Patents

Samson Mataraso holds a patent titled "Methods for evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease and applications thereof." This patent describes methods to compute glycemia tests and applications thereof. Additionally, it outlines methods to compute the risk of atherosclerotic cardiovascular disease. The systems he developed utilize analyte measurements to determine a patient's glycemic status or cardiovascular disease risk, which can serve as a basis for treatment.

Career Highlights

Samson Mataraso is affiliated with Leland Stanford Junior University, where he continues to advance his research and innovations. His work is pivotal in bridging the gap between technology and healthcare, providing new solutions for managing chronic diseases.

Collaborations

Samson collaborates with notable colleagues, including Sophia Miryam Schüssler-Fiorenza Rose and Kevin Contrepois. Their combined expertise enhances the research and development of innovative solutions in the medical field.

Conclusion

Samson Mataraso's contributions to the evaluation and treatment of glycemic dysregulation and cardiovascular disease exemplify the impact of innovation in healthcare. His work not only advances medical technology but also improves patient outcomes through effective treatment methods.